SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.18+2.4%12:52 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (17381)3/13/1998 11:59:00 AM
From: Flagrante Delictu  Read Replies (1) of 32384
 
Henry, << JAKs, STATs, and Src Kinases: Obligate Partners in Cytokine Signalling << This, the topic of one of the AACR meetings, appears to be very significant for LGND. Yet, this is the first time I've seen anything in print about "obligate partners" for LGND's JAK/STAT's technology. We know that rexinoids are "obligate partners" in heterodimers, but apparently only in intracellular signalling, as opposed to cytokine signalling. Can you update us on where LGND sits regarding Src Kinases, and, whether the inclusion of Src Kinases, with JAKs & STATs, as "obligate partners" augments or diminishes the hegemony of our JAK/STAT technology? Naturally, when you complete this assignment, you'll receive the usual honorarium we & the lurkers & peepers promptly provide for your tireless efforts in our behalf.Bernie

,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext